or Try an Advanced Search...

    Diagnostic Products Stocks List

    Symbol Grade Name % Change
    RMD A ResMed Inc. (CHESS)   9.60
    CSL C CSL Limited   -1.85
    IIQ D INOVIQ Ltd -1.87
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research Medical Instruments & Supplies
    Related Stock Lists: Health Marketing Anatomy Apnea Biopharmaceutical Biotechnology Breast Cancer Cancer Cancers Chronic Obstructive Pulmonary Disease Copd Disease Diseases Disorders Exosome Headgear In Vitro Infectious Causes Of Cancer Intellectual Property Manufacturing

    Related ETFs - A few ETFs which own one or more of the above listed Diagnostic Products stocks.

    Symbol Grade Name Weight
    YMAX C BetaShares Australian Top 20 Equity Yield Maximiser Fund 12.19
    VLC C Vanguard MSCI Australian Large Companies Index ETF   10.05
    IESG C iShares Core MSCI Australia ESG Leaders ETF 9.75
    ILC C iShares S&P/ASX 20 Index Fund   9.46
    OZXX B Global X Australia Ex Financials & Resources ETF 9.36
    View all Diagnostic Products ETFs...
    Compare ETFs
    Compare IESG to ILC Compare YMAX to IESG Compare YMAX to VLC

        Diagnostic Products Stocks Recent News

        Date Stock Title
        Apr 25 RMD Compared to Estimates, ResMed (RMD) Q3 Earnings: A Look at Key Metrics
        Apr 25 RMD ResMed Inc (RMD) Q3 Fiscal 2024 Earnings: Surpasses Analyst Expectations with Strong Growth
        Apr 25 RMD ResMed (RMD) Q3 Earnings and Revenues Surpass Estimates
        Apr 25 RMD ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2024
        Apr 24 RMD Watch These 3 MedTech Stocks This Earnings Season: Beat or Miss?
        Apr 24 CSL Travere Therapeutics and CSL Vifor Announce European Commission Approves FILSPARI® (sparsentan) for the treatment of IgA Nephropathy
        Apr 24 CSL CSL Vifor and Travere Therapeutics Announce European Commission approves FILSPARI® (sparsentan) for the treatment of IgA Nephropathy
        Apr 23 RMD Stryker (SYK) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
        Apr 22 RMD ResMed (RMD) Q3 Earnings Preview: What You Should Know Beyond the Headline Estimates
        Related Industries: Biotechnology Diagnostics & Research Medical Instruments & Supplies
        Related Stock Lists: Health Marketing Anatomy Apnea Biopharmaceutical Biotechnology Breast Cancer Cancer Cancers Chronic Obstructive Pulmonary Disease Copd Disease Diseases Disorders Exosome Headgear In Vitro Infectious Causes Of Cancer Intellectual Property Manufacturing
        Diagnostic Products

        Browse All Tags